Login / Signup

Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology.

Agnieszka OrzińskaAnna KluskaAneta BalabasMagdalena PiatkowskaMaria KuleckaJerzy OstrowskiMichal MikulaMarzena DębskaMałgorzata UhrynowskaKatarzyna Guz
Published in: Transfusion (2022)
The use of Ion AmpliSeq HD technology improves the prediction of feto-maternal incompatibility, increasing the sensitivity of BG/HPA NIPT and serving confirmation of the fetal DNA at the same workflow.
Keyphrases
  • birth weight
  • pregnancy outcomes
  • circulating tumor
  • cell free
  • single molecule
  • pregnant women
  • weight gain
  • electronic health record
  • gestational age
  • preterm birth